Encryption Standards for APIs: What Pharma Needs to Know
Key Takeaways
Pharma companies must meet stricter encryption rules by 2026 to safeguard patient data. The updated HIPAA Security Rule now mandates encryption for all electronic protected health information (ePHI) exchanged via APIs. Non-compliance risks fines up to $250,000 per violation. Key takeaways include:
- Encryption for Data in Transit: Use TLS 1.2 or TLS 1.3 protocols; older versions are no longer acceptable.
- Encryption for Data at Rest: Implement AES-256 encryption with proper key management.
- Multi-Factor Authentication (MFA): Required for all systems accessing ePHI.
- Key Management: Regular key rotation, separation of duties, and clear recovery protocols are mandatory.
- Network Segmentation: Large-scale ePHI handlers must isolate sensitive systems from general networks.
These changes aim to reduce breaches, which affected over 133 million records in 2023 alone. Immediate actions include auditing API endpoints, upgrading encryption protocols, and managing encryption keys securely. Failure to comply could lead to severe financial and reputational damage.
HIPAA Requirements: Encryption at Rest and in Transit #HIPAA #cybersecurity #breach #data #it #phi
sbb-itb-8f61039
Encryption Requirements for Pharma API Data Exchange
2026 HIPAA Encryption Requirements for Pharmaceutical APIs
The 2026 update to the HIPAA Security Rule introduces a major shift: encryption is now mandatory for all patient data exchanged via APIs. This marks the first time encryption has been required across the board. Organizations can no longer rely on alternative methods or compensating measures - they must encrypt electronic protected health information (ePHI) both at rest and in transit to remain compliant.
"Under the proposed rule, encryption of electronic protected health information at rest and in transit becomes a required implementation specification, not addressable. This means covered entities and business associates can no longer document an alternative approach - they must encrypt, or be out of compliance."
– Selah Digital
This change signals a move toward stricter technical controls, replacing the previous flexibility of risk-based assessments. Pharmaceutical companies exchanging ePHI through APIs must now implement these standards across all systems, from patient portals to clinical trial platforms. Below, we’ll break down the encryption requirements and technical specifications mandated by the 2026 rule.
HIPAA Encryption Standards for APIs
The 2026 update requires APIs handling ePHI to meet several stringent standards. Multi-factor authentication (MFA) is now a must for every workforce member accessing ePHI systems. Organizations are also required to implement detailed key management procedures, including regular key rotation, separation of duties, and clear recovery and revocation protocols. For companies managing large ePHI volumes, network segmentation is mandatory. This involves isolating sensitive systems from general-purpose networks using tools like firewalls or VLANs, minimizing the risk of lateral movement by attackers. Additionally, organizations must perform regular vulnerability scans and address critical issues within defined timelines.
Standards for Data in Transit
APIs transmitting ePHI must use TLS 1.2 or 1.3 encryption protocols. Older versions, such as TLS 1.0 or 1.1, are no longer acceptable and must be replaced immediately. Selah Digital emphasizes:
"Organizations using deprecated encryption standards such as TLS 1.0 or 1.1 for any system handling ePHI must remediate regardless of compensating controls."
To comply, organizations need to audit their API endpoints and internal data flows to identify and upgrade outdated protocols. For APIs hosted in the cloud, encryption must be actively managed by the organization - not left to the provider’s default settings.
Standards for Data at Rest
Beyond securing data in transit, the updated rule also focuses on protecting stored ePHI. Organizations are required to use AES-256 encryption for data at rest. Robust key management practices, supported by tools like Hardware Security Modules (HSMs) or Key Management Services (KMS), are vital. These tools automate key rotation, enforce separation of duties, and maintain audit trails for key access. Failures in key management have historically contributed to significant breaches.
The table below summarizes the key technical requirements under the 2026 HIPAA standards:
| Requirement Category | 2026 HIPAA Standard | Technical Specification |
|---|---|---|
| Data in Transit | Mandatory | TLS 1.2 or TLS 1.3 |
| Data at Rest | Mandatory | AES-256 |
| Key Management | Mandatory | Documented rotation, recovery, and revocation |
| User Access | Mandatory | MFA for all workforce members |
| Network Security | Mandatory | Network segmentation (for entities above ePHI thresholds) |
These updates aim to elevate the security of ePHI, ensuring that both data in motion and at rest are protected under uniformly enforced standards. Organizations must act swiftly to align their systems with these requirements.
How to Manage Encryption Keys in Pharma APIs
Encryption keys are at the heart of API security, and poor management can leave your system vulnerable. The upcoming 2026 HIPAA updates mandate strict key management protocols, making it essential to handle keys properly. Historically, inadequate key management has been a major factor in healthcare data breaches. The sections below outline practical steps to ensure strong key management.
Key Management Systems (KMS)
Cloud-based Key Management Systems (KMS) like AWS Key Management Service, Azure Key Vault, and Google Cloud KMS offer centralized control for managing cryptographic keys. These platforms use FIPS 140‑3 validated Hardware Security Modules (HSMs) to secure keys. Starting September 22, 2026, FIPS 140‑2 certifications will no longer be valid for new deployments, making FIPS 140‑3 compliance a must.
Most KMS platforms employ envelope encryption, which separates key management from data processing. This reduces the risk of exposure. For example, pharmaceutical companies transitioning to Azure Health Data Services (replacing the Azure API for FHIR on September 30, 2026) should use Azure Key Vault to implement customer-managed keys (CMK). These keys add an extra encryption layer for data at rest, ensuring compliance with HIPAA's stringent encryption standards.
When choosing a KMS, look for features like separation of duties, which lets you control who can manage keys versus who can use them to decrypt data. Always opt for customer-managed keys over provider defaults to maintain control over the key lifecycle and access policies. Enable features like soft delete in Azure Key Vault to prevent accidental data loss, and use tools like AWS CloudTrail to log every key access request for auditing purposes.
Key Rotation and Renewal
Rotating encryption keys regularly minimizes the risk if a key is compromised. Set rotation schedules based on data sensitivity - monthly or quarterly rotations are common. Automating the process reduces human error. Tools like AWS Secrets Manager, HashiCorp Vault, and Google Cloud KMS can handle key generation, distribution, and invalidation automatically.
"Regular key rotation ensures that your system is resilient to manual rotation, whether due to a security breach or the need to migrate your application to a stronger cryptographic algorithm." – Google Cloud Documentation
Key rotation doesn’t re-encrypt existing data. You’ll need to decide whether to keep old keys for legacy data or re-encrypt using the new key. Managing keys through their lifecycle - generation, active use, deactivation for legacy data, and destruction - helps you stay organized and systematic.
Avoid hardcoding API keys into your source code. Instead, use environment variables or secret management services. Integrate key rotation into your CI/CD pipelines to ensure new keys are deployed consistently. Also, monitor for unusual API usage patterns or unexpected IP access, which could indicate a compromised key.
By implementing effective key rotation strategies, you not only reduce security risks but also strengthen compliance measures like safe harbor protections.
Safe Harbor Protections
Strong key management can help meet HHS safe harbor criteria. If encrypted data is breached but the keys remain secure, the data is considered "unusable, unreadable, or indecipherable." This could exempt your organization from certain breach notification requirements.
"With effective cryptographic key management, data that is encrypted can still be protected even in the event of a breach, since encrypted data cannot be decrypted without the right keys." – CMS Information Security and Privacy Program
To maintain safe harbor status, store encryption keys separately from the data they protect, ideally using a dedicated KMS or HSM. Implement role-based access control (RBAC) and multi-factor authentication (MFA) for anyone accessing sensitive keys. Log every key access instance - who accessed it, when, and for what purpose - to ensure accountability and detect suspicious activity. Ensure application code never directly accesses encryption keys, and securely clear memory after key use. These practices strengthen your API encryption framework, a critical component of protecting pharmaceutical data.
With HIPAA penalties reaching up to $250,000 per violation and 84.7% of healthcare organizations experiencing API security incidents in 2025, managing encryption keys effectively is not optional - it’s essential.
Common Encryption Mistakes in Third-Party Pharma API Integrations
When working with third-party integrations in the pharmaceutical industry, encryption missteps can jeopardize both data security and compliance. These integrations are essential for operations but come with unique challenges. As their use increases, so does the risk of critical errors that could expose sensitive patient information and lead to regulatory penalties.
Data Minimization and Field-Level Encryption
Transmitting more data than necessary increases vulnerability. Under the HIPAA Privacy Rule, the "minimum necessary" standard requires using or disclosing only the essential amount of Protected Health Information (PHI) for a specific purpose. Field-level encryption offers a focused approach by securing individual sensitive fields - such as Social Security Numbers, Medical Record Numbers, or prescription details - rather than encrypting the entire data payload. To further minimize risks, surrogate identifiers like non-identifiable UUIDs can replace actual patient data, reducing exposure if the information is intercepted.
Avoiding PHI in URLs and Logs
Embedding PHI in URLs is a common but avoidable mistake. Even though HTTPS encrypts data during transmission, URLs containing PHI can still appear unencrypted in server and browser logs. This makes them accessible to unauthorized parties. Instead, use POST methods for transmitting sensitive data and configure loggers to mask or exclude these parameters.
"Although HTTPS will protect the parameters against interception, log entries for the GET requests will show the unencrypted full URL on both the client and server." – Red Anne, Information Security Expert
Logged PHI itself becomes sensitive and must be treated with the same security standards as other forms of PHI. This includes encrypting logs at rest, restricting access, and retaining them for six years to meet HIPAA requirements. Without proper safeguards, developers or IT staff who lack clinical authorization could inadvertently access PHI during system maintenance.
To mitigate these risks, logging frameworks should automatically redact sensitive fields (e.g., replacing a 10-digit ID with "**********") before writing logs to disk. If routing identifiers are necessary, include them in custom HTTP headers, which are less likely to be logged by default. Additionally, adopt the "minimum necessary" principle for logging: record that an action occurred (e.g., "User X accessed Record Y") without including clinical details. These steps align with broader HIPAA encryption requirements.
Ensuring Encryption Compliance in BAAs
Business Associate Agreements (BAAs) are legally required when third-party vendors handle PHI, but many pharmaceutical companies overlook the need to specify encryption standards in these contracts. This oversight creates compliance gaps. BAAs should explicitly require strong encryption protocols - such as AES-256 for data at rest and TLS 1.3 for data in transit - along with measures like network segmentation, detailed audit protocols, and real-time anomaly detection.
The importance of these safeguards was highlighted by a February 2024 ransomware attack on Change Healthcare, a subsidiary of UnitedHealth Group, which compromised the PHI of approximately 192.7 million individuals. With healthcare data breaches averaging costs of $10.10 million, specifying encryption requirements in BAAs is not just a best practice - it’s essential for protecting sensitive information.
API Encryption in Pharma: 2026 and Beyond
Pharmaceutical companies are facing new challenges as they work to comply with updated HIPAA encryption mandates. These changes, set to take effect in 2026, bring stricter regulations and demand significant adjustments in how organizations protect electronic protected health information (ePHI). Below, we break down the key updates and actions required to meet these evolving standards.
Impact of 2026 HIPAA Encryption Updates
The 2026 HIPAA Security Rule update makes encryption a mandatory requirement, covering ePHI both at rest and in transit. This means all API endpoints must adopt AES-256 encryption for data at rest and TLS 1.2 or 1.3 for data in transit. Older protocols must be replaced immediately. The urgency of these updates is underscored by incidents like the early 2024 Change Healthcare breach, which exposed the PHI of over 100 million Americans.
"The 2026 HIPAA Security Rule changes represent a fundamental shift in how HHS expects healthcare organizations to secure their technology infrastructure. Mandatory multi-factor authentication, universal encryption, 24-hour incident reporting, and zero-trust architecture principles are no longer best practices -- they are about to become legal requirements."
– Daniel Ashcraft, Founder, Of Ash and Fire
One of the most notable changes is the reduction in the timeline for reporting security incidents - from 60 days to just 24 hours after detection. To meet this requirement, organizations will need automated monitoring systems capable of real-time breach detection. Multi-factor authentication (MFA) is now required for any system accessing ePHI, including APIs used for service-to-service communication. Once the rule is finalized, expected in May 2026, organizations will have a 180-day window to achieve compliance.
Encryption key management practices are also receiving more attention. Companies must now document procedures for key rotation, ensure separation of duties for key access, and establish protocols for key recovery and revocation. Additionally, network segmentation is becoming a required safeguard to limit the lateral movement of attackers, especially for entities managing large amounts of ePHI.
Here’s a snapshot of the key requirements and their timelines:
| Requirement | Timeline | Key Action |
|---|---|---|
| Encryption Mandate | May 2026 (finalization) | Upgrade APIs to AES-256 (at rest) and TLS 1.2/1.3 (in transit) |
| Compliance Deadline | 180 days post-finalization | Address deprecated protocols and implement MFA |
| Incident Reporting | Upon adoption | Set up automated monitoring for 24-hour breach reporting |
| Annual Risk Assessments | Ongoing | Perform comprehensive annual risk assessments |
Emerging Encryption Technologies
In addition to the HIPAA updates, other regulations are introducing new encryption requirements that will shape the future of data security. For example, the EU's Cyber Resilience Act (CRA), effective September 11, 2026, will require organizations to report security incidents within 24 hours and disclose actively exploited vulnerabilities. Non-compliance could result in fines of up to €15 million or 2.5% of global annual turnover.
By December 2027, Software Bills of Materials (SBOMs) will also become mandatory. This will ensure transparency in the software supply chain, requiring companies to automate SBOM generation within their CI/CD pipelines to quickly address vulnerabilities in third-party libraries.
A shift toward Zero-Trust architecture is becoming more prominent under these new regulations. Identity-centric access control, microsegmentation, and continuous session verification are steering organizations away from traditional perimeter-based security models.
For those using cloud infrastructure, selecting a HIPAA-compliant provider is no longer enough. Companies must actively verify that encryption is enabled for all cloud storage resources handling ePHI. FedRAMP Authorized cloud infrastructures are well-positioned for these changes, as their encryption and key management practices align closely with the updated HIPAA requirements.
Conclusion
Pharmaceutical companies can no longer view encryption as just a "nice-to-have" feature. With the upcoming HIPAA Security Rule explicitly requiring encryption for all electronic protected health information (ePHI) - both at rest and in transit - it's clear that organizations must act now to bolster their data protection strategies. Beyond compliance, proper encryption offers a critical advantage: it qualifies data for safe harbor protections under the Breach Notification Rule, which can significantly reduce the financial and reputational damage from breaches.
Recent incidents highlight the dangers of weak encryption practices. For example, one breach exploited a remote portal that lacked multi-factor authentication (MFA) - a gap that the new regulations address by mandating MFA for all systems handling ePHI. This serves as a stark reminder that encryption alone isn’t enough; it must be part of a broader security framework.
Effective encryption involves more than just deploying AES-256 and TLS 1.3. Organizations need to establish strong key management protocols and ensure that every third-party API provider signs a Business Associate Agreement before engaging in any data exchange.
These efforts aren’t just about compliance - they directly safeguard a company’s finances and reputation. Danielle Barbour of Kiteworks emphasizes this point:
"Healthcare organizations that implement AES-256 encryption with sound key management practices can avoid breach notification costs that frequently reach millions of dollars".
Strong encryption and proper key management do more than mitigate risks - they also shield companies from the hefty penalties regulators impose. In 2025 alone, the Office for Civil Rights resolved 21 enforcement cases, with fines ranging from $25,000 to $3 million .
The message is clear: immediate action is non-negotiable. Companies should start by disabling outdated protocols like TLS 1.0 and 1.1, conducting annual risk assessments, implementing centralized audit logging, and maintaining thorough documentation of encryption practices. These aren’t just regulatory requirements - they’re essential steps to protect the sensitive patient data pharmaceutical companies are entrusted to safeguard.
FAQs
How can we confirm all API paths use TLS 1.2 or 1.3?
To make sure all API paths are secured with TLS 1.2 or 1.3, start by configuring your API servers to enforce these protocols while disabling older versions. This step ensures outdated and less secure protocols are not used. Next, use security testing tools to scan your endpoints and verify compliance with these requirements. Finally, create and maintain clear documentation outlining the policy to use TLS 1.2 or 1.3 for all API paths. This not only strengthens security but also helps align with healthcare data protection standards.
What’s the best way to handle AES-256 encryption keys without risking exposure?
To manage AES-256 encryption keys securely, it's crucial to follow a few key practices. Start with FIPS-validated systems for generating keys, ensuring they meet strict security standards. Implement role-based access controls to limit who can access or manage these keys. Regularly rotate the keys - ideally every 90 to 180 days - to reduce the risk of compromise.
When it's time to retire a key, always disable it before destruction to prevent misuse. Additionally, maintain detailed audit logs for every key-related operation, from generation to deletion. These measures not only reduce the risk of exposure but also help meet compliance requirements for data security.
Do we need a BAA with every third-party API vendor that touches ePHI?
Yes, you need a Business Associate Agreement (BAA) with any third-party API vendor that creates, receives, transmits, or stores protected health information (PHI) on behalf of a covered entity. This applies to vendors managing electronic PHI (ePHI) as well. Having these agreements in place is critical for maintaining HIPAA compliance and protecting sensitive patient information.
Related Blog Posts
Author
